Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Monday that its third quarter revenues rose 36 percent year over year, driven in part by ePlex analyzer placements.

For the three months ended Sept. 30, the firm reported revenues of $15.8 million, up from $11.6 million a year ago, and beating the consensus Wall Street estimate of $15.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.